Introduction
============

This is the 20th annual report of the European IVF-monitoring Consortium (EIM) under the umbrella of ESHRE containing the data on ART, IUI and fertility preservation (FP) as reported by 40 participating European countries in 2016 ([Supplementary Data](#sup1){ref-type="supplementary-material"}).

Eighteen previous reports published in *Human Reproduction* (<https://www.eshre.eu/Data-collection-and-research/Consortia/EIM/Publications.aspx>) and one in *Human Reproduction Open* ([@hoaa032-B3]) covered treatment cycles from 1997 to 2015. As in previous reports, the printed version contains the five most relevant tables. Twenty additional supplementary tables (Supplementary Tables SI--SXX) are available online. The settings of the data are consistent with those published in the previous reports, aiming at easier comparison and assessment of trends. For the first time, an additional set of data dealing with FP was collected and added to this report.

Material and methods
====================

Data collected on an aggregate basis were provided by 40 European countries, covering the following treatment modalities: IVF, ICSI, frozen embryo replacement (FER), egg donation (ED), IVM, pooled data on preimplantation genetic testing (PGT) and frozen oocyte replacement (FOR). With regards to IUI, split data for use of husband's/partner's semen (IUI-H) and donor semen (IUI-D) were included. The report includes treatments started between 1 January and 31 December 2016. Data on pregnancies and deliveries were derived from follow-up of treatments performed in 2016. In addition, data on FP, including numbers and types of cryostored material and interventions for use of stored material between 1 January and 31 December 2016, were provided by 11 countries and reported as aggregated data of events that occurred during a 1-year period.

The national representatives of 44 countries were asked to fill out questionnaires, with other involved stakeholders when applicable. The same data sets as in 2015 and additional data on FP for a total of 10 specific modules were sent using software designed for the specific requirements of this data collection (Dynamic Solutions, Barcelona, Spain). Besides evaluation of the plausibility of the results by the software, other detected inconsistencies were clarified through contacts between the administrator of the ESHRE central office (V.G.) and the national representative.

The data were analysed and presented similarly to previous reports (although with some additional subgroups of interventions) and footnotes to the tables were added for clarification on diverging results reported by individual countries, when applicable.

The terminology used was based on the glossary of the International Committee for Monitoring Assisted Reproductive Technology ([@hoaa032-B69978222]).

Results
=======

Participation and data completeness
-----------------------------------

[Table I](#hoaa032-T1){ref-type="table"} shows the number of institutions or clinics offering ART services with all available treatment modalities and those performing IUI (IUI-H and IUI-D). In comparison to the 2015 data, both the total number of reporting clinics (1343 in 2015 to 1347 in 2016) and the overall number of reported treatments (849 811 in 2015 to 918 159 in 2016, +8.0%) increased. Among the 51 European countries, 44 are EIM members including 28 that are members of the European Union (Supplementary Table SI). Non-EIM members are mainly smaller countries not offering ART services. In 2016, 40 countries delivered data to EIM with Luxemburg providing data as a new EIM member. Croatia, Georgia, Slovakia and Turkey failed to deliver data (9.1% of EIM members, 11.6% in 2015). In 18 countries (45% of reporting countries), all of the ART clinics within the country reported data sets. Currently, 1347 clinics reported their data (91.8% of all known clinics in Europe, 90.6% in 2015). As in 2015, the four European countries with the largest treatment numbers in 2016 were Spain (140 909), Russia (121 232), France (104 773) and Germany (99 226).

###### 

Treatment frequencies after ART in European countries in 2016.

  Country                                IVF clinics in the country   Cycles/million\*                                                                                                
  ------------------------------------- ---------------------------- ------------------ ------ ------ --------- --------- --------- -------- -------- ----- ------ --------- -------- ------
  Albania                                            10                      1                            0        83        63        0        29      0     0       175             
  Armenia                                            5                       2            6      2       66        112       107                61                    346             
  Austria                                            26                      26                         1459      5600      2662                0                    9721      5886    1110
  Belarus                                            8                       7            10     7      1310      1394       270       7        16      0     0      2997             
  Belgium                                            18                      18           29     29     2715     13 628    12 052     1100     1163    176    95    30 929    14 136   2738
  Bosnia-Herzegovina, Federation part                6                       1                            0        89        46                                       135             
  Bulgaria                                           35                      35           1      1       920      6879      1813      379      1018                 11 009     7153    1544
  Cyprus                                             6                       6                           158       942       325       31      271                   1727      9089    2020
  Czech Republic                                     41                      40                           0      15 020    12 258              5265                 32 543            
  Denmark                                            19                      19           35     33     6319      5703      5059      112      484      0     19    17 696    15 917   3088
  Estonia                                            6                       6            6      6       641      1184       927       2       191      0     7      2952     11 515   2245
  Finland                                            17                      17           22     22     2756      1970      3661       73      731      0            9191      9116    1673
  France                                            102                     102          181    181    22 773    45 214    33 792     1422     1158    70    344    104 773    9066    1619
  Germany                                           134                     128                        17 594    56 587    25 045                                   99 226            
  Greece                                             39                      39           39     39     2304     15 121     4785      1251     4462     2     51    27 976    13 922   2603
  Hungary                                            13                      11                         1049      3902       632                25                   5608             
  Iceland                                            1                       1            1      1       199       162       229       0        54      0     0       644      9248    1928
  Ireland                                                                    1                           215       231       260                                      706             
  Italy                                             200                     200          360    360     7584     46 322    14 990     2844     4359          1460   77 559     7014    1280
  Kazakhstan                                         10                      5                           994      1671       958      154      683                   4460             
  Latvia                                             6                       3            6      3       352       527       515       7       127                   1528             
  Lithuania                                          6                       5            6      5       295       371       92                         0     0       758             
  Luxembourg                                         1                       1            5      0       312       354       314       0        0       0     0       980              1684
  Malta                                              2                       2            2      0        7        273        0        0        0       0     79      359      3624    822
  Moldova                                            4                       3            5      3        0        739       181                14                    934             
  Montenegro                                         5                       4            5      4        7        501       58                                       566             
  North Macedonia                                    7                       5            0      0       420      2100       288       0       122      0     4      2934             
  Norway                                             11                      11           11     11     3587      3330      3363                        0     0     10 280    10 101   1963
  Poland                                             39                      39           0      38      881     16 984    11 375     692      1085    33    299    31 349             816
  Portugal                                           24                      24           26     26     2462      3751      2008      127      988      1     28     9365      1726    907
  Romania                                            19                      11           19     11     1445      2034      1495       6        29                   5009             
  Russia                                            199                     151                        34 058    43 766    31 051     4420     7122    260   558    121 235           
  Serbia                                             12                      3            12     3       170       93        23        0        0       0     0       286             
  Slovenia                                           3                       3            3      3      1017      2268      1389       37       7       0     7      4725     12 717   2288
  Spain                                             247                     240          366    291     5624     56 640    27 559    10 238   39 530   41    1277   140 909           
  Sweden                                             18                      17                  0      6235      6088      6080      304      282                  18 989            
  Switzerland                                        27                      27                         1042      5059      4859                                    10 960    10 329   1309
  The Nederlands                                     13                      13           90     0      6781      7803     12 545     772                           27 901     5403    1639
  Ukraine                                            46                      38           17     17     1167      9454      6967      1658     1157           8     20 411            
  UK                                                 82                      82          101    101    21 084    23 273    18 311     1433     3494    71    642    68 308     5240    1041
  **All**                                           1467                    1347         1364   1197   156 002   407 222   248 407   27 069   73 927   654   4878   918 159    7794    1410

Treatment cycles in IVF and ICSI refer to initiated cycles.

For Austria, Belgium, Iceland, Lithuania and Malta, treatment cycles IVF refer to aspirations. For Austria, Belgium, Iceland and Lithuania, treatment cycles ICSI refer to aspirations. For Austria and Belgium, the total number of initiated cycles was only available for IVF and ICSI together, being 10 097 and 19 163, respectively.

For the Czech Republic, no distinction between IVF and ICSI is made. All cycles are counted as ICSI. For Belgium, there are 824 extra aspiration cycles for which it is not known whether IVF or ICSI was performed.

Treatment cycles in frozen embryo replacement (FER) refer to thawings.

For Finland, Hungary, Kazakhstan, Sweden and the Netherlands, treatment cycles refer to transfers.

Treatment cycles in preimplantation genetic testing (PGT) contain both fresh and frozen cycles and refer to initiated cycles in the fresh cycles and aspirations in the frozen cycles.

Treatment cycles in egg donation (ED) refer to donation cycles and contain fresh and frozen cycles.

ED fresh: for France and Iceland, treatment cycles refer to aspirations. ED frozen: for France, Iceland, Kazakhstan, Spain, Sweden and the UK, treatment cycles refer to aspirations.

Treatment cycles in IVM refer to aspirations.

Treatment cycles in frozen oocyte replacement (FOR) refer to thawings.

Size of the clinics and reporting methods
-----------------------------------------

The size of reporting clinics, defined by the number of treatment cycles, remains highly variable between and inside countries (Supplementary Table SII). In 2016, clinics with cycle numbers between 200 and 499 were the most common (29.5% vs 29.9%). Small clinics providing less than 100 treatments cycles per year were present in 16 countries (40% of the countries) and the proportion of clinics performing more than 1000 treatment cycles per year seems on a slight rise over the years with 19.4% in 2016, 17.9% in 2015, 18.3% in 2014, 17.8% in 2013 and 16.9% in 2012.

Country-specific requirements and reporting methods are presented in Supplementary Table SIII. Data collection was either voluntary (19 out of 40 countries) or compulsory. Twenty countries had only a partial reporting and provided the data mainly on a voluntary basis (16/20 countries) to medical organizations/professional societies (10 countries), based on a single person's initiatives (five countries) or to the national health authority (one country).

By contrast, complete reporting was achieved mainly when data collection was compulsory (17/20 countries) with subsequent data communication to the national health authority (all but two countries).

Transfer of data was mostly done on an aggregate basis (26 countries/40 in 2016, as in 2015).

Number of treatment cycles per technique and availability
---------------------------------------------------------

In 2016, 918 159 treatment cycles were reported to EIM (68 348 more than in 2015, +8.0%). Since 1997 increasing numbers of clinics reported to EIM, which so far recorded more than 9 772 904 treatments cycles and the birth of more than 1 861 760 infants ([Table II](#hoaa032-T2){ref-type="table"}). As shown in [Table I](#hoaa032-T1){ref-type="table"}, compared to 2015, 10 countries reported fewer treatment cycles, but Ireland and Luxemburg were now able to provide data. Furthermore, the largest increment in reported treatment numbers was recorded in Spain (+21 034, +9 clinics), France (+10 855, same number of clinics) and Russia (+10 512, +7 clinics). The numbers of treatment cycles per technique in 2016 are presented in [Table I:](#hoaa032-T1){ref-type="table"} ICSI was the most used (407 222, 44.4% of treatment cycles vs 45.4% in 2015). Cycles of IVF, FER, ED, FOR, PGT and IVM represented 17%, 27%, 8.1%, 0.5%, 2.9% and 0.0007% of all cycles, respectively. While the distribution of the available techniques remained similar to 2015 (IVF, FER, ED, FOR, PGT and IVM, respectively 18.4%, 25.7%, 7.6%, 0.5%, 2.5% and 0.0003%), for each single technique higher cycle numbers were registered. The steepest rise in treatment numbers was observed in FER (+13.9%), in ED (+14.7%), in FOR (+13.6%), in PGT (+27.4%) and IVM (+246.8%). The proportion of FER relative to fresh treatments (IVF + ICSI) is still on the rise (44.1% vs 40.3% in 2015 and 37.8% in 2014). The highest proportions were reached in Armenia (75.9%), Belgium (73.7%), Czech Republic (81.6%), Finland (77.5%), Switzerland (79.6%) and The Netherlands (86.0%). No FER were reported/performed in Malta according to their legislation.

###### 

Number of institutions offering ART services, treatment cycles and infants born after ART in Europe, 1997--2016.

  Year     Countries   Clinics    Cycles     Cycle increase (%)   Infants born
  ------- ----------- --------- ----------- -------------------- --------------
  1997        18         482      203 225                            35 314
  1998        18         521      232 225          +14.3             21 433
  1999        21         537      249 624           +7.5             26 212
  2000        22         569      275 187          +10.2             17 887
  2001        23         579      289 690           +5.3             24 963
  2002        25         631      324 238          +11.9             24 283
  2003        28         725      365 103          +12.6             68 931
  2004        29         785      367 056           +0.5             67 973
  2005        30         923      419 037          +14.2             72 184
  2006        32         998      458 759           +9.5             87 705
  2007        33        1029      493 420           +7.7             96 690
  2008        36        1051      532 260           +7.9            107 383
  2009        34        1005      537 463           +1.0            109 239
  2010        31         991      550 296           +2.4            120 676
  2011        33        1314      609 973          +11.3            134 106
  2012        34        1354      640 144           +4.9            143 844
  2013        38        1169      686 271           +7.2            149 466
  2014        39        1279      776 556          +13.1            170 163
  2015        38        1343      849 811          +10.2            187 542
  2016        40        1347      918 159           +8.0            195 766
  Total                          9 772 904                         1 861 760

Among the total of 563 224 fresh treatments (ICSI + IVF), 72.3% were performed with ICSI, showing a rise of +1.2% compared to 2015. [Figure 1](#hoaa032-F1){ref-type="fig"} shows the evolution and continuing preponderance of ICSI over conventional IVF and the increase in the proportion of FER cycles relative to fresh cycles (IVF + ICSI).

![**Proportion of IVF versus ICSI and frozen embryo replacement (FER) in Europe, 1997--2016**.](hoaa032f1){#hoaa032-F1}

The number of cycles per million women of reproductive age and per million inhabitants is shown in [Table I](#hoaa032-T1){ref-type="table"} and Supplementary Table SIV. Availability of ART was calculated for the 20 countries with full coverage (Supplementary Table SIV). While there is a huge variability in availability (range 1726--15 917 per million women aged 15--45 years), ART was most available in Denmark and least available in Portugal. Consequently, the proportion of newborns resulting from ART born in Denmark was 5.1% of all newborns in that country. Other countries that reported high proportions were Austria (6.2%) and Slovenia (5.5%).

Pregnancies and deliveries after treatment
------------------------------------------

[Table III](#hoaa032-T3){ref-type="table"} shows PR and delivery rates (DR) after IVF or ICSI and after FER (after both IVF and ICSI). Because, as in previous years, data on numbers of initiated cycles were incomplete, the outcome data were calculated per aspiration.

###### 

Results after ART in 2016.

  Country                                  IVF      ICSI     FER                                                                    
  ------------------------------------- --------- --------- ------ ------ --------- ------ ------ --------- ------ ------ --------- -----
  Albania                                  83                                83      41.0   33.7     63      41.3   23.8     70     
  Armemia                                  178       66      24.2   21.2     112     25.9   21.4     107     36.4   28.0     114     0.3
  Austria                                10 097     1459     33.9           5600     28.5   46.5    2662     34.3           5479     6.2
  Belarus                                 2704      1241     35.9   27.2    1328     34.7   24.9     270     25.9   14.8     798     0.7
  Belgium                                19 163     2715     27.8   20.3   13 628    24.2   16.0   12 052    27.8   17.1    5566     4.6
  Bosnia-Herzegovina, Federation part      89                                80      33.8   26.3     46      23.9   13.0     31     
  Bulgaria                                7799       868     21.7   13.6    5660     26.3   19.7    1813     32.2   25.0            
  Cyprus                                  1100       146     39.0   33.6     813     39.1   37.4     325     40.6   33.5            
  Czech Republic                         15 020                            14 661    22.5   15.0   12 258    30.2   18.9    6278     5.6
  Denmark                                12 022     6309     20.9   14.1    5701     22.5   17.7    5059     24.7   19.9    3157     5.1
  Estonia                                 1825       635     25.2   19.2    1184     28.0   20.9     927     22.8   15.6     664     4.7
  Finland                                 4726      2573     23.8   18.3    1879     23.8   18.3                            1607     3.0
  France                                 67 987    20 058    21.1   18.3   41 587    21.4   18.8   33 792    21.4   18.3   20 187    2.6
  Germany                                74 181    16 234    28.8   19.4   52 235    27.0   18.2   25 045    27.6   17.4   20 540   
  Greece                                 17 425     2256     26.9   18.6   13 082    23.0   15.3    4785     36.7   23.9    6346    
  Hungary                                 4951      1043     31.4           3871     32.3                                           
  Iceland                                            199     25.6   23.1     162     30.2   25.3     229     29.3   20.1     155     3.8
  Ireland                                  446       183     40.4   33.9     214     38.8   30.4     260     38.8   30.0     213    
  Italy                                  53 906     6857     21.6   15.1   41 899    18.7   12.3   14 990    27.5   19.3   12 053    2.5
  Kazakhstan                              2665       974     40.1   26.4    1648     38.3   25.9                            1497     0.4
  Latvia                                   879       352     36.9   22.2     527     27.5   15.2     515     40.2   28.3     366    
  Lithuania                                          295     52.9   7.1      371     42.6   1.6      92      23.9            38      0.1
  Luxembourg                               666       296     13.2   9.8      319     19.7   16.9     314     25.8   17.2     155     2.6
  Malta                                    273        7                      187                                             40      0.9
  Moldova                                  739                               731     41.9   34.7     181     51.9   45.3            
  Montenegro                               508        7      57.1   28.6     496     27.0   21.4     58      31.0   27.6     156     2.1
  Norway                                  6917      3412     28.8   24.2    3172     29.6   24.8    3363     23.5   18.6            
  North Macedonia                         2520       390     33.8   10.5    2068     35.5   18.9     288     34.4   21.2     628     3.4
  Poland                                 17 865      873     28.6   23.1   16 935    25.8   15.6   11 375    35.9   23.6    6336    
  Portugal                                6213      2279     29.4   22.6    3676     23.0   17.4    2008     30.9   22.8    2333     2.7
  Romania                                 3479      1399     31.6   23.4    1954     28.3   22.7    1495     30.6   19.7    1288     0.7
  Russia                                 77 824    33 129    29.9   21.8   42 542    25.9   18.4   31 051    38.5   27.5   30 770    1.7
  Serbia                                   263       166     25.9   21.7     87      41.4   37.9     23      39.1   39.1     100     0.2
  Slovenia                                3285       916     33.0   25.8    2220     25.8   20.7    1389     31.3   23.0    1116     5.5
  Spain                                  62 264     5229     26.3   19.1   45 373    22.4   16.3   27 559    34.4   22.9   31 715    7.7
  Sweden                                 12 323     5803     29.3   24.3    5744     27.4   23.2                            4923     4.1
  Switzerland                             6101       958     24.3   17.8    4621     24.5   19.1    4859     23.4   16.6    2160     2.5
  The Nederlands                         14 584     5819     31.0   22.2    7038     32.9   24.6                                    
  Ukraine                                10 621     1141     36.8   25.7    9243     30.1   24.6    6967     46.0   38.6    7622     1.9
  UK                                     44 357    18 483    32.8   28.5   23 097    33.1   28.8   18 311    34.2   29.5   21 265    2.7
  All                                    568 048   144 770   28.0   20.8   375 828   25.0   18.5   224 531   30.9   22.0   195 766   2.9

Total rates refer to these countries were all data were reported for the given technique:

ART infants also include ED.

For IVF and ICSI, there were for Austria, Czech Republic, Finland, France, Greece, Kazakhstan, Latvia, Poland, Portugal, Russia, Serbia, Spain and Sweden, respectively 2650, 3, 810, 14, 254, 43, 13, 319, 4, 817, 1, 345 and 4 deliveries with unknown outcome. These were accepted as singletons to calculate the ART infants.

For FER, there were for Czech Republic, Finland, France, Greece, Kazakhstan, Latvia, Poland, Russia, Spain and Sweden, respectively 1, 797, 8, 42, 4, 15, 228, 471, 89 and 2 deliveries with unknown outcome. These were accepted as singletons to calculate the ART infants.

For ED, there were for Germany, Italy, Kazakhstan, Romania and Slovenia, respectively 3, 17, 14, 222 and 7582 deliveries with unknown outcome. These were accepted as singletons to calculate the ART infants.

For PGD, there were for Finland, Germany and Romania, respectively 1, 1 and 154 deliveries with unknown outcome. These were accepted as singleton to calculate the ART infants.

In the Czech Republic, IVF and ICSI were reported together, no details on pregnancies and deliveries.

Among the 40 reporting countries, 33 were able to provide both pregnancy and delivery data per aspiration after IVF and ICSI and per thawing for FER (completeness rate for both: 82.5%). In Supplementary Table SIV, the numbers of deliveries for the 20 countries that had full coverage of the reporting are presented.

As in all previous reports, the PR and DR (for all types of treatment cycles) varied significantly from one country to another. Per aspiration, PR ranged from 13.2% to 57.1% and DR from 12.3% to 46.5% in fresh cycles after IVF or ICSI (excluding Lithuania where DR was not available for two of the five centres reporting pregnancies). After FER per thawing, the PR were between 21.4% and 51.9% and the DR varied between 13% and 45.3%. Overall, PR and DR were higher for FER cycles (per thawing) than for both fresh IVF and ICSI cycles (per aspiration) ([Table III](#hoaa032-T3){ref-type="table"}).

For the third time, «freeze all» cycles were collected (Supplementary Table SV) including cryopreservation of all oocytes reported by 10 countries (six in 2015 and 2014) and of all embryos by 22 countries (21 in 2015 and 2014). The highest proportions of freeze all cycles per aspiration were 3.5% at the oocyte and 17.3% at the embryo level.

Cycle numbers, aspirations, transfers, pregnancies, deliveries in IVF, ICSI and FER (after both IVF and ICSI) by country are given in the Supplementary Tables SV--SVII.

As in 2015, ED cycle numbers were available for 26 countries although 29 provided outcome data (Supplementary Table SVIII). Most donation cycles were carried out in Spain, Russia, the Czech Republic and Greece. Freshly collected oocytes were used in 33 406 ED cycles and frozen oocytes (FOR) in 11 757 ED cycles. PR were only available per embryo transfer for freshly donated oocytes (49.4%, in 2015 49.6%) and for thawed oocytes (41%, in 2015 40.3%). Outcomes for the different countries show a high variability ranging between 9.7% and 66.5%% for fresh oocytes and between 29.5% and 67.4% for thawed oocytes. A total of 22 497 deliveries were reported (19 849 in 2015 and 17 259 in 2014) representing a further increase of +13.3%.

Age distribution
----------------

As seen in Supplementary Tables SIX and SX, age distributions of women treated with IVF and ICSI varied between countries. Not all countries were able to provide data on the age distribution in ICSI (six missing) and in IVF (seven missing), some because no IVF treatments were carried out. The highest percentage of women aged40 years and older undergoing aspiration for IVF was found in Greece (as in 2015), whereas the highest percentage of women aged \<34 years was found in Montenegro (as in 2015) followed by Ukraine. For ICSI, the highest percentage of women aged 40 years and older undergoing aspiration was found in Greece (as in 2015), whereas the highest percentage of women undergoing aspiration aged \<34 years was recorded in Kazakhstan (in Albania in 2015 and 2014). As expected, there was an age-dependent decline of the reported PR and DR for IVF and ICSI treatment cycles with DR in women aged 40 years and older, ranging between 0% and 13.1%, and 0% and 42.9% (on small numbers), respectively. With regard to FER (Supplementary Table SXI), the age-related decline was also visible and DR among women aged 40 years and older ranged between 0% and 34.3%.

In ED cycles (Supplementary Table SXII), the age of the recipient women did not influence outcome data and overall PR and DR were higher than in fresh and FER cycles (in partner donation).

Numbers of embryos transferred and multiple births
--------------------------------------------------

The subgroups defined by the number of embryos transferred after IVF and ICSI together as well as multiple births are presented in [Table IV](#hoaa032-T4){ref-type="table"}. Five countries did not report on either the number of replaced embryos per treatment cycle or on multiplicity. While overall most transfers involved the replacement of two embryos (51.9% of the transfer cycles), the proportion of transfers of only one embryo per cycle continued to rise (41.5% vs 37.7% in 2015), and the number of transfers of three or more embryos continued to decrease ([Fig. 2](#hoaa032-F2){ref-type="fig"}). The number of countries reporting more than 50% of single embryo transfers (elective or not) increased to 10 (same eight as in 2015 plus Slovenia and UK). As in 2015, only Serbia reported more than 50% of transfers with three embryos. The highest proportion of transfers of four or more embryos was recorded in Greece (4.2% vs 4.9% in 2015). Information on the type of embryos (cleavage or blastocyst) transferred was not available for each of the subgroups but, for the first time, the embryo stage at the transfer was collected. Taking into account that the embryo stage at transfer was unknown for 44.5% of the fresh (IVF+ICSI) cycles, 41.9% of the transfers were performed at the blastocyst stage and the corresponding figure for FER was 62.2%.

![**Number of embryos transferred in IVF and ICSI during fresh cycles in Europe, 1997--2016**.](hoaa032f2){#hoaa032-F2}

###### 

Number of embryos transferred after ART and deliveries in 2016.

  Country                                   IVF + ICSI               FER                                                                                              
  ---------------------------------------- ------------ --------- --------- --------- ------- ------ ------ ------ ------ ----- -------- ------ ----- -------- ------ -----
  Albania                                       74         72         2         0      97.3    2.7    9.5    90.5   0.0    0.0     28     35.7   0.0     15     20.0   0.0
  Armemia                                      114         99        15         0      86.8    13.2   11.4   83.3   5.3    0.0     38     15.8   0.0     30     10.0   0.0
  Austria                                      8702       2484      6219        0      28.5    71.5   65.7   34.0   0.3    0.0    5210    10.2   0.1                  
  Belarus                                      2300       1462       838        0      63.6    36.4   18.2   73.1   8.7    0.0    668     10.5   0.3     40     15.0   0.0
  Belgium                                     13 081      8856      4225        0      67.7    32.3   62.8   31.9   4.7    0.6    2734    9.2    0.1    2055    7.4    0.0
  Bosnia-Herzegovina, Federation part           67         31        36         0      46.3    53.7   46.3   50.7   3.0    0.0     21     14.3   0.0     6      16.7   0.0
  Bulgaria                                                                                                                                                            
  Cyprus                                                                                                                                                              
  Czech Republic                              10 727                         10 727                   70.0   29.4   0.6    0.0    2199    7.7    0.1    2313    9.0    0.2
  Denmark                                      9567       4832      2300      2435     67.8    32.2   71.0   28.7   0.2    0.0    1895    4.9    0.0    1008    4.4    0.0
  Estonia                                      1549        976       573        0      630\.   37.0   44.7   48.9   6.3    0.0    370     14.3   0.3    145     16.6   0.0
  Finland                                      3396                           3396                    85.7   14.3   0.0    0.0    810                   797           
  France                                      45 534                         45 534                   46.5   48.7   4.5    0.3   11 506   13.1   0.1    6189    7.8    0.1
  Germany                                     56 413     39 850    16 563       0      70.6    29.4   21.6   69.2   9.2    0.0   12 688   21.0   0.5    4352    15.2   0.4
  Greece                                       9494       6367      3127        0      67.1    32.9   22.5   59.3   14.0   4.2    2415    22.4   0.3    1146    23.6   0.0
  Hungary                                      4505                           4505                    22.9   56.4   18.1   2.6                                        
  Iceland                                      287                             287                    84.3   15.7   0.0    0.0     87     1.1    0.0     46     4.3    0.0
  Ireland                                      338         338        0                100.0   0.0                                127     4.7    0.0     78     2.6    0.0
  Italy                                       36 038                         36 038                   30.2   50.3   17.9   1.6    6196    15.6   0.4    2890    7.4    0.2
  Kazakhstan                                   2238       2238        0         0      100.0   0.0                                674     11.3   0.0    405     32.9   0.0
  Latvia                                       630         428       182       10      69.0    29.4   48.4   51.3   0.3    0.0    158     13.1   0.7    146     7.6    0.8
  Lithuania                                    661         78        30        553     72.2    27.8   13.0   52.8   34.3   0.0     27     33.3   3.7                  
  Luxembourg                                   424         416        8         0      98.1    1.9    38.4   61.6   0.0    0.0     83     15.7   0.0     54     9.3    0.0
  Malta                                        181         181        0         0      100.0   0.0    0.0    0.0    0.0    0.0     34     17.6   0.0                  
  Moldova                                                                                                                                                             
  Montenegro                                   448         377       71         0      84.2    15.8   16.7   43.8   39.1   0.4    108     25.9   0.0     16     25.0   0.0
  Norway                                                                                                                                                              
  North Macedonia                              2059       1650       409        0      80.1    19.9   25.6   66.1   8.2    0.0    432     16.2   0.7     61     14.8   0.0
  Poland                                      12 345      7104      5241        0      57.5    42.5   52.8   46.6   0.6    0.0    2848    7.6    0.1    2686    7.1    0.0
  Portugal                                     4382       3382      1000        0      77.2    22.8   32.6   66.1   1.3    0.0    1155    19.4   0.3    457     13.6   0.0
  Romania                                      2376        967      1408        1      40.7    59.3   22.5   60.0   17.1   0.4    771     21.3   0.1    294     16.7   0.7
  Russia                                      57 621     15 612    30 092    11 917    34.2    65.8   40.1   56.8   3.0    0.1   15 044   17.7   0.4    8529    14.7   0.2
  Serbia                                       227         223        4         0      98.2    1.8    12.8   26.9   60.4   0.0     69     23.5   4.4     9      0.0    0.0
  Slovenia                                     2582       1362      1220        0      52.7    47.3   53.1   46.5   0.4    0.0    695     9.2    0.0    319     8.8    0.0
  Spain                                       32 982     26 354     5385      1243     83.0    17.0   31.5   65.0   3.5    0.0    8378    17.0   0.2    6319    13.7   0.1
  Sweden                                       9482       7065      2417        0      74.5    25.5   82.5   17.5   0.0    0.0    2746    3.0    0.1    1909    2.6    0.1
  Switzerland                                  4253       3274       979        0      77.0    23.0   31.0   62.0   7.0    0.0    1053    15.6   0.5    808     15.0   0.2
  The Nederlands                                                                                                                                                      
  Ukraine                                      6861       1863      4998        0      27.2    72.8   27.7   60.7   11.5   0.0    2571    21.9   0.2    2691    20.6   0.0
  UK                                          36 986     15 572    21 414       0      42.1    57.9   54.7   42.0   3.3    0.0   11 927   11.2   0.2    5406    11.0   0.2
  All[\*](#tblfn18){ref-type="table-fn"}     376 348     153 513   108 756   116 646   59.1    41.9   41.5   51.9   6.2    0.4   95 765   14.9   0.3   51 219   11.9   0.2

Totals refer only to these countries where data on number of transferred embryos and on multiplicity were reported.

Percentages of cleavage and blastocyst stage transfers are calculated on the proportion of transfers where the day of transfer is known.

The day of transfer is unknown in 25.5%, 1.6%, 83.7%, 0.05%, 20.7% and 3.8% of all transfers in Denmark, Latvia, Lithuania, Romania, Russia and Spain, respectively.

As a result of decreasing numbers of embryos replaced per transfer, the proportion of both twin and triplet deliveries continued to decline. In 2016, twin and triplet rates for fresh IVF and ICSI cycles together were 14.9% (range 1.1--35.7) and 0.3% (range 0--4.4), respectively. Corresponding results for FER were 11.9% and 0.2%. In the two countries with the highest rates of single embryo replacement in fresh cycles (84.3% for Iceland and 82.5% for Sweden), twin rates were as low as 1.1% and 3%, respectively.

Additional information on pregnancy and delivery data are provided in Supplementary Tables SXIII and SXIV. The reported incidence of pregnancy loss was 16.4% after IVF + ICSI (in 2015: 16.4%) and 18.6% after FER (in 2015: 20.6%). The proportion of lost to follow-up was 7.8% after IVF+ICSI (in 2015: 6.3%) and 7.5% after FER (in 2015: 7.4%).

Perinatal risks and complications
---------------------------------

In 2016, data on premature deliveries were available from 18 countries (18 countries in 2015). Premature DR based on multiplicity are presented in Supplementary Table SXV. Data from fresh IVF and ICSI, FER and ED are pooled. The incidence of extreme preterm birth (20--27 gestational weeks at delivery) was 1.1% in singletons (1.3% in 2015), 3.3% in twins (3.7% in 2015) and 8.4% in triplets (13.4% in 2015). Very premature birth rates (28--32 gestational weeks at delivery) were recorded in 2.2% of singletons, 10.5% of twin pregnancies (in 2015: 9.9%) and 45% in triplet pregnancies (in 2015: 39.2%). The evolution of the proportion of premature deliveries before 37 weeks per embryo transfer according to multiplicity is shown in [Fig. 3](#hoaa032-F3){ref-type="fig"}. Term deliveries (≥37 weeks) were achieved in 85.9% (86.4% in 2015) of singleton pregnancies, 44.1% (44.7% in 2015) of twin pregnancies and 8.8% (7.5% in 2015) of triplet pregnancies.

![**Proportion of premature deliveries (\<37 weeks of gestation in relation to pregnancies ≥37 week of gestation) in singleton, in twin and in triplet pregnancies in Europe, 2006--2016**.](hoaa032f3){#hoaa032-F3}

Complications related to oocyte retrievals were reported by 33 countries (31 in 2015) and foetal reductions by 35 countries (26 in 2015) (Supplementary Table SXVI). The total number of reported cases of ovarian hyperstimulation syndrome (OHSS) (grades 3 to 5) was 1928, corresponding to a reported incidence of 0.21% (2167 cases in 2015; 0.25%). Other complications were less frequent (1471 cases) with a total reported incidence of 0.2% including 0.1% and 0.001% for bleeding and infection, respectively. No maternal death was reported in 2016 (2 out of 850 000 treatment cycles in 2015). A total of 553 foetal reductions were reported, the majority from UK, Belgium and Spain, as in 2015.

PGT/PGT-A
---------

[Table I](#hoaa032-T1){ref-type="table"} includes PGT and PGT-A activities, which were reported from 22 countries (23 in 2015, 22 in 2014). The main contributors were Spain, Russia and Italy. The number of treatment cycles amounted to 27 069 representing 3.3% of initiated IVF + ICSI and FER cycles together (21 041; 2.8% in 2015). More details on PGT/PGT-A activities can be found in the annual reports of the ESHRE PGT consortium ([@hoaa032-B57796403])

These treatments involved 19 461 fresh cycles and 7242 thawings, resulting in 5776 fresh and 6434 FER. In total, 2418 pregnancies (41.9% per transfer) and 1875 deliveries (32.5% per transfer) resulted from fresh cycles. Corresponding figures for FER were 2811 (43.7% per transfer) and 2259 (35.1% per transfer).

IVM
---

A total of 654 treatments with IVM were reported from eight countries (265 from eight countries in 2015) ([Table I](#hoaa032-T1){ref-type="table"}). Most IVM cycles were reported from Russia, as in 2015. A total of 391 transfers resulted in 103 pregnancies (26.3% per transfer) and 43 deliveries (11% per transfer).

FOR
---

A total number of 4878 thawing cycles were reported by 15 countries (4294 from 17 countries in 2015) ([Table I](#hoaa032-T1){ref-type="table"}) with Italy and Spain being the largest contributors (1460 and 1277 cycles, respectively). Among 3854 transfers, 1138 resulted in pregnancies (29.5%; 30.7% in 2015) and 808 in deliveries (21%; 20.6% in 2015).

IUI
---

For each participating country, the institutions performing and collecting data on IUI are listed in [Table V](#hoaa032-T5){ref-type="table"}. Data on IUI with husband semen (IUI-H, Supplementary Table SXVII) or using donors' semen (IUI-D, Supplementary Table SXVIII) were collected by a total of 1197 institutions in 28 and 23 countries (25 and 21 in 2015, respectively. Among 113 450 IUI-H (139 050 in 2015) and 46 883 IUI-D (49 001 in 2015) reported cycles, the numbers were the highest for IUI-H in Spain, Italy and Belgium, and for IUI-D in Spain, Denmark and Belgium.

###### 

IUI with husband (IUI-H) or donor (IUI-D) semen in 2016.

  Country                                    IUI-H    IUI-D                                                                     
  ---------------------------------------- --------- -------- ------ ------- ------ ----- -------- ------ ------ ------- ------ -----
  Albania                                                                                                                       
  Armemia                                     275       68     24.7   79.6    20.4   0.0     48      11    22.9   88.9    11.1   0.0
  Austria                                                                                                                       
  Belarus                                    1017      102     10.0   91.1    8.9    0.0     18      8     44.4   100.0   0.0    0.0
  Belgium                                   12 296     904     7.4    95.2    4.6    0.1    8444    896    10.6   96.3    3.7    0.0
  Bosnia-Herzegovina, Federation part         77        4      5.2    100.0   0.0    0.0                                        
  Bulgaria                                   2515      219     8.7    90.0    10.0   0.0    554      59    10.6   94.9    5.1    0.0
  Cyprus                                                                                                                        
  Czech Republic                                                                                                                
  Denmark                                    9977      1118    11.2   90.0    9.8    0.2    9390    569    6.1    94.4    5.5    0.2
  Estonia                                     90        2      2.2    100.0   0.0    0.0    122      11    9.0    100.0   0.0    0.0
  Finland                                    2936      249     8.5                          1125    134    11.9                 
  France                                    49 498     5254    10.6   90.4    9.4    0.2    2870    544    19.0   89.9    9.7    0.4
  Georgia                                                                                                                       
  Germany                                                                                                                       
  Greece                                     3266      210     6.4    93.7    6.3    0.0    309      42    13.6   91.9    5.4    2.7
  Hungary                                                                                                                       
  Iceland                                     69        6      8.7    100.0   0.0    0.0    167      21    12.6   100.0   0.0    0.0
  Ireland                                     81        8      9.9    100.0   0.0    0.0                                        
  Italy                                     21 053     1531    7.3    91.2    8.2    0.6    714      98    13.7   83.7    11.2   5.1
  Kazakhstan                                 2622       23     0.9    100.0   0.0    0.0                                        
  Latvia                                      103       13     12.6   100.0   0.0    0.0     64      5     7.8    100.0   0.0    0.0
  Lithuania                                   246       15     6.1    100.0   0.0    0.0                                        
  Luxembourg                                  264       34     12.9   94.1    5.9    0.0     84      10    11.9   100.0   0.0    0.0
  Malta                                                                                                                         
  Moldova                                     81        9      11.1   100.0   0.0    0.0                                        
  Montenegro                                                                                193      19    9.8    89.5    10.5   0.0
  Norway                                      325       47     14.5   83.0    17.0   0.0    614     119    19.4   95.8    4.2    0.0
  North Macedonia                            1108       23     2.1    95.7    4.3    0.0     79      4     5.1    100.0   0.0    0.0
  Poland                                    11 149     751     6.7    94.5    5.1    0.4    2053    225    11.0   91.7    7.9    0.5
  Portugal                                   2095      190     9.1    85.7    13.8   0.5    185      42    22.7   92.9    7.1    0.0
  Romania                                    2542      143     5.6    66.2    33.8   0.0    278      27    9.7    77.8    22.2   0.0
  Russia                                     9106      1002    11.0   93.1    6.6    0.3    3897    545    14.0   93.4    6.3    0.4
  Serbia                                      393       32     8.1    96.9    3.1    0.0                                        
  Slovenia                                    551       43     7.8    88.4    11.6   0.0                                        
  Spain                                     24 130     2404    10.0   90.5    9.2    0.3   12 333   1914   15.5   88.3    11.2   0.5
  Sweden                                                                                    1168    196    16.8   96.9    3.1    0.0
  Switzerland                                                                                                                   
  The Nederlands                                                                                                                
  Ukraine                                    1032       91     8.8    95.6    4.4    0.0    360      43    11.9   97.7    2.3    0.0
  UK                                         4051                                           5398    707    13.1   92.6    6.8    0.6
  All[\*](#tblfn21){ref-type="table-fn"}    162 948   14 495   8.9    91.0    8.8    0.3   50 467   6249   12.4   91.9    7.7    0.4

Total refers to these countries where data were reported, and mean percentage was computed on countries with complete information.

DR could be calculated for 109 399 IUI-H cycles (8.5% vs 7.8% in 2015) and 46 883 for IUI-D cycles (12% vs 12% in 2015).

Singleton deliveries were the most frequent regardless of the age group with an overall rate of 91.3% for IUI-H and 92% for IUI-D (90.6% in IUI-H, 92.1% in IUI-D in 2015). Twin and triplet rates were 8.4% and 0.3%, respectively for IUI-H, and 7.5% and 0.4% for IUI-D, respectively (in 2015: 8.9% and 0.5%, respectively for IUI-H and 7.3% and 0.6%, respectively for IUI-D).

Sum of fresh and FER ('cumulative') DR
--------------------------------------

Supplementary Table SXIX provides an estimate of a cumulative DR (different from a true cumulative DR including outcomes of all transfers performed from one aspiration). It was calculated as the ratio between the total number of deliveries from fresh embryo transfers and FER performed during a year (numerator) and the number of aspirations during the same year (denominator). The calculation included data from 38 countries (35 countries in 2015) where an overall rate of 29.6% was recorded. The benefit taken from additional FER (over the DR from fresh embryo transfers) was 10.5%, with the highest benefits recorded for Ukraine (+26.1%), Ireland (+19.6%), Finland and Albania (for both +18.1%) and the lowest for North Macedonia (+2.5%), Belarus (+1.6%) and Lithuania (0%).

Cross-border reproductive care
------------------------------

Ten countries reported data on cross-border patients: Albania, Belarus, Denmark, Greece, Montenegro, Portugal, Serbia, Slovenia, Spain and Switzerland. A total of 19 239 cycles (14 273 in 2015) were reported, 22.1% (29.4% in 2015) of which involved IVF/ICSI with the couple's own gametes, 46.6% (47.1% in 2015) were oocyte donations and 21.8% (22.3% in 2015) were IVF or ICSI with semen donation. In addition, 7062 IUI with sperm donation (7714 in 2015) were registered. Information regarding the countries of origin was very incomplete and not reliable enough to obtain any conclusive information. The main reasons reported by patients were to have access to a technique not legally available in their home country (39.1%; 41.7% in 2015) or to seek a higher quality treatment (23.6%; 16.6% in 2015). In 13 291 cycles (mainly from Spain), there was another, not specified, reason to go abroad.

FP
--

For the first time data on FP are reported here. Eleven countries were able to provide data on a total number of 13 689 interventions (Supplementary Table SXX) in pre- and postpubertal patients, both for medical and non-medical reasons. The majority of interventions consisted of the cryopreservation of ejaculated sperm (*n* = 7877 from 11 countries) and the cryopreservation of oocytes (*n* = 4907 from eight countries). Ovarian tissue cryopreservation was reported by two and seven countries, respectively, for pre- and postpubertal patients with use of postpubertal tissue through transplantation reported in three countries (Greece, Portugal and Spain). Testicular tissue cryopreservation in postpubertal patients and prepubertal boys was reported from six countries and from France only (*n* = 124), respectively.

Discussion
==========

This is the 20th annual report of the activity collected by EIM from European registries on ART, IUI and for the first time also on FP. From 1997 to 2016, the EIM of ESHRE has reported close to 10 million treatments cycles (9 772 904) that have led to the birth of more than 1.8 million infants.

Despite difficulties caused by the data collection system in a number of countries, the number of participating countries has increased over the years. The current report presents the analysis of data collected in 2016 from 40 European countries (38 in 2015) with Luxemburg providing data for the first time as a new EIM member. Non-EIM members are mainly smaller countries not offering ART services (*n* = 5), except for Azerbaijan and Kosovo. Amongst EIM members, Croatia, Georgia, Slovakia and Turkey did not deliver data most likely due to organizational problems or local regulatory problems ([@hoaa032-B1]).

Excluding the five small European countries in which ART is not available, the rate of participation at the country level is as high as 87% of European countries (90.9% of EIM members) while at the level of IVF clinics, the proportion of those reporting data sets is 91.8% (vs 90.6% in 2015; [@hoaa032-B3]). Although the participation of some of the countries fluctuated over time, reported ART treatment numbers are on a continuous rise (+8% as compared to 2015) as are the infants born from ART (+4.4% compared to 2015).

Moreover, although the level of completeness is highly variable among countries, 20 countries were able to present data from all IVF clinics (in 2015: 18 and in 2014: 14 countries). Efforts to achieve increased participation and higher completeness of the data aim at an improved transparency and vigilance in reproductive care. However, because of the variety in collection systems, absence or limited presence of data validation methods, differences in definitions of collected items and country-specific practices (e.g. freeze all cycles, embryo transfer policy) that may, among other reasons, be influenced by economic issues, interpretation of the data should remain cautious. Progress towards harmonization of data collections could prove helpful in the future to achieve a higher quality of outcome data for professionals but also for other stakeholders involved in societal, political and economic decisions in medically assisted reproduction (MAR), as well as tissue and cell banking for FP.

Access to care is one of the important and very relevant pieces of information generated by the EIM. Considering that it was estimated that 1500 ART cycles per million inhabitants per year should cover the needs in infertility care ([@hoaa032-B1888532]), we noticed that 60% of the countries in which complete data sets were available (12 out of 20) reached this level of access in 2016 (vs 55.6% in 2012, 64.3% in 2014 and 61.1% in 2015). Using the number of women of reproductive age as the denominator and eliminating thereby the impact of age differences among countries, access to care (based on all types of cycles) appeared highly variable, ranging from 1726 to 15 917 cycles per women aged 15--45 years. As the population needs in ART were estimated at a time when FER was not current practice (2001), any interpretation of treatment availability should be cautious. Indeed, FER cycles were included in the calculation on availability and represent a quite high proportion of ART cycles nowadays (in 2016, 44.1% of ART cycles when fresh IVF+ICSI cycles are used as the denominator). Moreover, considering that cross-border care may have an impact on accessibility in some countries, data interpretation will remain difficult before full traceability of all MAR procedures becomes available.

Considering the different treatment modalities, ICSI remains the most used and seems to have stabilized in recent years ([Table I;](#hoaa032-T1){ref-type="table"}[Fig. 1](#hoaa032-F1){ref-type="fig"}), whereas FER is the second most used technique with a progressive increase over the years in the proportion of FER relative to fresh IVF and ICSI cycles (37.8% in 2014, 40.3% in 2015 and 44% in 2016). Changes in ART practices with higher numbers of freeze all cycles, a reduced number of embryos replaced per transfer and higher survival rates of cryopreserved embryos with the implementation of vitrification ([@hoaa032-B9]) may all explain this evolution. While freeze all cycles have been registered since 2014, showing a 42% increase in reported cycles in 2016 compared to 2015 (Supplementary Table SV), the distinction between techniques of cryopreservation could not be registered by EIM. Enhanced reporting of IVM, PGT, ED and FOR in 2016 may be a reflection of the increased use of these treatment modalities. Expanding the data collection in large registries such as EIM for techniques like IVM and PGT-A, or to other new techniques or laboratory adjuncts ([@hoaa032-B6]), could help to underscore analysis of their efficacy and safety in the future.

Owing to segmentation of treatments (i.e. treatment is not always a continuous sequence of single procedures but may, for example, include several oocyte retrievals for one transfer or several transfers for frozen cycles), such as for freeze all cycles, and the implementation of new technologies in ART, the cumulative DR per cycle or per aspiration will become the most important outcome indicator of treatment effectiveness. To date, the EIM has gathered data on an aggregate basis precluding thereby the calculation of true cumulative livebirths rates. Hence, as a surrogate indicator or proxy of true cumulative rates, fresh and FER during the same calendar year have been considered. Based on data from 38 countries, cumulative DR reached 29.6% during a 1-year period with a multiple DR of 13.8% and a rate of single embryo transfers of 41.5% in 2016. The absence of a link between cryopreserved embryos and their original cycle, and the limited observation period of 1 year where an unknown number of ART cycles was performed, do not allow comparisons with other registries. However, after seven consecutive ART cycles (fresh and frozen-thawed embryo transfer cycles counted consecutively) the 2011 data registered by the National Perinatal Epidemiology and Statistics Unit for Australia--New Zealand, including 73.2% single embryo transfers, showed a cumulative livebirth rate of 41.1% and a multiple DR of only 6.9% (National Perinatal Epidemiology and Statistics Unit, <https://npesu.unsw.edu.au>).

Besides local regulations and economic issues that may restrict treatment strategies, the improved awareness of ART outcomes by patients and physicians should guide future decisions. In this regard, the reduction in the number of embryos replaced in a cycle is a main trend that has been recorded by the EIM registry over the years ([Fig. 2](#hoaa032-F2){ref-type="fig"}). While the transfer of two embryos remains the most frequently performed approach (51.9% of the transfers), single embryo transfers (whether elective or not) represented 41.5% of the transfers in 2016 and were carried out in the majority of treatment cycles for 10 of the countries. Transfers of four or more embryos were performed in very few countries and represent only 0.4% of all transfers. The evolution of the transfer policies in clinics often parallels the implementation of embryo culture to the blastocyst stage. However, the quality of evidence to support blastocyst transfers is still low ([@hoaa032-B5]). For the first time in 2016, EIM data collection allowed separate analysis of blastocyst and cleavage stage embryo transfers, showing that the majority of embryos were transferred at the blastocyst stage (41.9% for fresh IVF + ICSI and 62.2% for FER). Although figures are not available for DR yet, PR per transfer were the highest for blastocysts (39.7% vs 28.3% for cleavage stage embryos). Keeping in mind that the objective of an IVF/ICSI treatment is the delivery of a single healthy child, with a twin pregnancy being regarded as a complication ([@hoaa032-B8]), further progress towards a reduction of prematurity associated with multiple births should be obtained at the expense of a reduced proportion of double embryo transfers. Indeed, whereas triplet rates remain low after a significant drop over the years ([@hoaa032-B4]), twin rates did not follow the same decreasing slope and the resulting prematurity (≤37 weeks) was still observed in more than half of the deliveries. Compared to singleton deliveries the risk of extreme prematurity was increased by 3-fold and of very preterm birth by nearly 5-fold for twin deliveries. Rates of twins and triplets were slightly lower after FER than after fresh IVF + ICSI treatments, which could also contribute to the decreasing multiple deliveries recorded in the recent years. Furthermore, the practice of foetal reduction for the prevention of multiple births was reported by 35 countries. However, it is not known which of these approaches is having the real impact on the reduction of multiples.

Regarding other safety aspects, no maternal death after ART was reported in 2016 (Supplementary Table SXVI) and the proportions of OHSS, infections and haemorrhage were low and quite stable over time although it is assumed that the complications of ART remain generally underreported.

The future of MAR registries should focus on the health of infants as an increasing number of children are born after ART, with incidences as high as 5.1% of all newborns in Denmark and 7.7% in Spain in 2016. Moreover, considering the increasing use of ED, FOR and the extension of using FP measures for medical reasons to non-medical indications, including planned postponement of motherhood, we may expect ART to contribute more and more to demography. Hence, transparency and vigilance in ART will more than ever be essential to all stakeholders with, as a main requirement, the need to level up the quality of collected data. Prospective compulsory registration systems, including an international coding system to follow gametes and embryos across country borders, should therefore become available to countries rather than the current retrospective aggregate data registration ([@hoaa032-B2]; [@hoaa032-B7]).
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Contact persons who are collaborators and represent the data collection programmes in participating European countries, 2016.

**Albania**

Prof. Orion Gliozheni, University Hospital for Obstetrics & Gynecology, Department of Obstetrics & Gynecology, Bul. B. Curri, Tirana, Albania. Tel: +355 4222 36 32; Fax: +355 42 257 688; Mobile: +355 68 20 29 313; E-mail: <glorion@abcom.al>

**Armenia**

Mr Eduard Hambartsoumian, Fertility Center, IVF Unit, 4 Tigvan Nets, 375 010 Yerevan, Armenia. Tel: +374 10 544 368; E-mail: <hambartsoumian@hotmail.com>

**Austria**

Prof. Dr Heinz Strohmer, Dr Obruca & Dr Strohmer Partnerschaft Goldenes Kreuz-Kinderwunschzentrum, Lazarettgasse 16-18, 1090 Wien, Austria. Tel: +43 401 111 400; Fax: +43 401 111 401; E-mail: <heinz.strohmer@kinderwunschzentrum.at>

**Belarus**

Dr Elena Petrovskaya (Alena Piatrouskaya), ART centre 'Embryo', Filimonova 53, 220053 Minsk, Belarus. Tel: +375 293 830 570; Email: <elenaembryoby@gmail.com>

Dr Oleg Tishkevich, Centre For Assisted Reproduction 'Embryo' Belivpul, Filimonova Str. 53, 220 114 Minsk, Belarus. Tel: +375 296 222 722; Fax: +375 172 376 404; Mobile: +375 296 222 722; E-mail: <tishol@tut.by>

**Belgium**

Dr Kris Bogaerts, I-Biostat, Kapucijnenvoer 35 bus 7001, 3000 Leuven, Belgium. Tel: +32 (0) 16 33 68 90; Fax: +32 (0) 16 33 70 15; E-mail: <kris.bogaerts@med.kuleuven.be>

Prof. Christine Wyns, Gynaecology-Andrology, Cliniques Universitaires Saint Luc, Service FIV- Andrology, Université Catholique de Louvain; Av. Hippocrate, 10, 1200 Brussels, Belgium. Tel: +32 27646576; Fax: +32 27649050; Mobile: +32 477943374; E-mail: <christine.wyns@uclouvain.be>

**Bosnia**

Professor Dr Devleta Balic, Zavod za humanu reprodukciju 'Dr Balic', Kojsino 25, 75000 Tuzla, Bosnia, Herzegovina. Tel: +387 35 260 650; Mobile: +387 611 402 22; E-mail: <drbalic@bih.net.ba>

**Bulgaria**

Irena Antonova, ESHRE certified clinical embryologist (2011), Ob/Gyn Hospital Dr Shechterev, 25--31, Hristo Blagoev Strasse, 1330 Sofia, Bulgaria. Tel: +359 887 127 651; E-mail: <irendreaming@gmail.com>

**Cyprus**

Dr Michael Pelekanos, AKESO Fertility Centre, 1, Pavlou Nirvana strasse, 3021 Limassol, Cyprus. Tel: +357 99645333; Fax: +357 25824477; Mobile: +30 6944248433; E-mail: <pelekanos@akeso.com>

**Czech Republic**

Dr Karel Rezabek, Medical Faculty, University Hopsital, CAR-Assisited Reproduction Center, Gyn/Ob Department, Apolinarska 18, 12000 Prague, Czech Republic. Tel: +420 224 967 479; Fax: +420 224 922 545; Mobile: +420 724 685 276; E-mail: <rezabek.ivf@seznam.cz>

Mgr. Jitka Markova, Institute of Health Information and Statistics of the Czech Republic, Palackeho namesti 4, 12801 Prague, Czech Republic. Tel: +420 224 972 832; Mobile: +420 721 827 532; E-mail: <jitka.markova@uzis.cz>

**Denmark**

Dr Josephine Lemmen, Vitanova, Fertility clinic, Vester Voldgade 106, 1552 Copenhagen, Denmark. Tel: +45 333 371 01; E-mail: <jglemmen@gmail.com>

**Estonia**

Dr Deniss Sõritsa, Tartu University Hospital and Elitre Clinic, Tartu, Estonia. Tel: +372 740 9930; Fax: +372 740 9931; E-mail: <soritsa@hotmail.com>

**Finland**

Prof. Mika Gissler, THL National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland. Tel: +385 29 524 7279; E-mail: <mika.gissler@thl.fi>

Dr Sari Pelkonen, Oulu University Hospital, departement of Obstetrics and Gynaecology, PO Box 23, 90029 Oys, Finalnd. Tel:+358 8 3153040; E-mail: <sari.pelkonen@fimnet.fi>

**France**

Dr Fabienne Pessione, Agence de la biomedecine, 1 av stade de France, 93 Saint Denis, France. Tel: +33 1 5593 69 46; E-mail: <fabienne.pessione@biomedecine.fr>

Prof. Jacques de Mouzon, 15--29 rue Guilleminot, 75014 Paris, France. Tel: +33 143 224 679; Mobile: +33 662 062 274; E-mail: <jacques.de.mouzon@gmail.com>

**Germany**

Dr Andreas Tandler, Schneider, Fertility Center Berlin, Spandauer damm 130, 14050 Berlin, Germany. Tel: +49 30 233 20 81 10; Fax: +49 30 233 20 81 19; E-mail: <tandler-schneider@fertilitycenter-berlin.de>

**Greece**

Prof. Sophia Kalantaridou; National Authority of Medically Assisted Reproduction, Ploutarxou 3, PO 10675 Athens. Tel: +30 213 2072000; E-mail: <secretary@eaiya.gov.gr>

**Hungary**

Prof. Janos Urbancsek, Semmelweis University, 1st Dept. of Ob/Gyn, Baross utca 27, 1088 Budapest, Hungary. Tel: +36 1 266 01 15; Fax: +36 1 266 01 15; E-mail: <urbjan@noi1.sote.hu>

Prof. G. Kosztolanyi, University of Pecs, Department of Medical Genetics and Child Development, Jozsef A.u, 7., 7623 Pecs, Hungary. Tel: +36 7 2535977; Fax: +36 7 2535972; E-mail: <gyorgy.kosztolanyi@aok.pte.hu>

**Iceland**

Mr Hilmar Bjorgvinsson, IVF Klinikin Reykjavik, Alfheimum 74, 104 Reykjavik, Iceland. Tel: +354 430 4000; Fax: +354 430 4040; E-mail: <Hilmar.bjorgvinsson@ivfklinikin.is>

**Ireland**

Dr Edgar Mocanu, Human Assisted Reproduction Ireland Rotunda Hospital, HARI Unit, Master's House, Parnell Square, 1 Dublin, Ireland. Tel: +353 180 72 732; Mobile: +353 86 818 839; Fax: +353 18 727 831; E-mail: <emocanu@rcsi.ie>

Jennifer Cloherty, Galway Fertility, Western distribution Road, Rahoon, Ireland. Tel: 35361476800; E-mail: <JCloherty@GFU.ie>

**Italy**

Dr Giulia Scaravelli, Istituto Superiore di Sanità, Registro Nazionale della Procreazione Medicalmente Assistita, CNESPS, Viale Regina Elena, 299, 00161 Roma. Tel: +3906 499 04 050; Fax: +39064 99 04 324; E-mail: <giulia.scaravelli@iss.it>

Dr Roberto de Luca, Istituto Superiore di Sanità, Registro Nazionale della Procreazione Medicalmente Assistita, CNESPS, Viale Regina Elena, 299, 00161 Roma. Tel: +3906 499 04 320; E-mail: <roberto.deluca@iss.it>

**Kazakhstan**

Prof. Dr Vyacheslav Lokshin, International Clinical Center for Reproductology 'Persona', Utepova street 32a, 00506 Almaty, Kazakhstan. Tel: +7 727 382 7777; Mobile: +7 701 755 8209; E-mail: <v_lokshin@persona-ivf.kz>

Dr Sholpan Karibayeva, International Clinical Center for Reproductology 'Persona', Utepova Street 32a, 00506 Almaty, Kazakhstan. Tel: +7 727 382 7777; E-mail: <sh.karibaeva@gmail.com>

**Latvia**

Dr Valeria Magomedova, Jusu Arsti Private Clinic, Apuzes 14, 1046 Riga, Latvia. Tel: +371 678 700 29; Fax: +371 678 704 29; E-mail: <godunova@inbox.lv>

**Lithuania**

Raminta Bausyte, Vilnius University Hospital Santaros Clinics, Santaros Fertility Center, Simono Staneviciaus 64-69, 07113 Vilnius, Lithuania. Tel: +370 620 86826; E-mail: <raminta.bausyte@gmail.com>

Ieva Masliukaite, Academic Medical Center, Center for Reproductive Medicine, Ijburglaan, 1086ZJ Amsterdam, The Netherlands. Tel: +31 653 688 815; E-mail: <i.masliukaite@amc.uva.nl>

**Luxembourg**

Dr Caroline Schilling, Centre Hospitalier de Luxembourg, Centre de Stérilité et de Médecine de Reproduction, Rue Fiederspiel 2, 1512 Luxembourg, Luxembourg. Tel: +352 44 11 32 30; Mobile: +352 66 13 13 912; E-mail: <schilling.caroline@chl.lu>

**Malta**

Dr Jean Calleja-Agius, University of Malta, 12, Mon Nid, Gianni Faure Street, TXN2421 Tarxien, Malta. Tel: +356 216 930 41; Mobile: +356 995 536 53; E-mail: <jean.calleja-agius@um.edu.mt>

**Moldova**

Prof. Dr Veaceslav Moshin, Medical Director at Repromed Moldova, Center of Mother @ Child protection, State Medical and Pharmaceutical University 'N.Testemitanu', Bd. Cuza Voda 29/1, Chisinau, Republic of Moldova. Tel: +37322 263855; Mobile: +37369724433; E-mail: <mosin@repromed.md>; <veaceslavmoshin@yahoo.com>

**Montenegro**

Dr Tatjana Motrenko Simic, Human Reproduction Center Budva, Prvomajska 4, 85310 Budva, Montenegro. Tel: +382 33402432; Mobile: +382 69 052 331; E-mail: <motrenko@t-com.me>

Dragana Vukicevic, Hospital 'Danilo I', Humana reprodukcija, Vuka Micunovica bb, 86000 Cetinje, Montenegro. Tel: +382 675 513 71; E-mail: <vukicevic.dragana@yahoo.com>

**The Netherlands**

Dr Jesper M.J. Smeenk, St Elisabeth Hospital Tilburg, Department of Obstetrics and Gynaecology, Hilv, The Netherlands. Tel: +31 13 539 31 08; Mobile: +31 622 753 853; E-mail: <j.smeenk@elisabeth.nl>

**North Macedonia**

Mr Zoranco Petanovski, Hospital ReMedika, Nas. Zelezara, 1000 Skopje, Macedonia. Tel: +389 224 475 45; Fax: +389 226 031 00; E-mail: <zpetanovski@yahoo.com>

**Norway**

Dr Liv Bente Romundstad, Spiren Fertility Clinic, Nardoskrenten 11, 7032 Trondheim, Norway. Tel: +47 73523000; Mobile: +47 90550207; E-mail: <libero@klinikkspiren.no>

**Poland**

Dr Anna Janicka, VitroLive, Wojska Polskiego 103, 70-483 Szczecin, Poland. Tel: +48 91 88 69 260; E-mail <anna.janicka@vitrolive.pl>

**Portugal**

Prof. Dr Carlos Calhaz-Jorge, CNPMA, assembleia da Republica, Palacio de Sao Bento, 1249-068 Lisboa, Portugal. Tel: +351 21 391 93 03; Fax: +351 21 391 75 02; E-mail: <calhazjorgec@gmail.com>

Ms Joana Maria Mesquita Guimaraes, Hospital Geral Santo Antonio, Largo Professor Abel Salazar, 4050-011 Porto, Portugal. Tel: +351 96 616 02 37; E-mail: <joanamesquitaguimaraes@gmail.com>

Ms Ana Rita Laranjeira, CNPMA, Assembleia da Republica, Palaio de Sao Bento 1249-068 Lisboa, Portugal. Tel: +351 21 391 93 03; Fax: +351 21 391 75 02; E-mail: <cnpma.correio@ar.parlamento.pt>

**Romania**

Mrs Ioana Rugescu, Gen Secretary of AER Embryologist association and Representative for Human Reproduction Romanian Society. Tel: +40744500267; E-mail: <irugescu@rdsmail.ro>

Dr Bogdan Doroftei; University of Medicine and Pharmacy Iasi; Teaching Hospital Obgyn 'Cuza Voda', Cuza Voda Str. 34, 700038 Iasi, Romania. Tel: +40 232 213 000/int. 176; Mobile: +40 744 515 297; E-mail: <bogdandoroftei@gmail.com>; <bogdan.doroftei@umfiasi.ro>

**Russia**

Dr Vladislav Korsak, International Center for Reproductive Medicine, General Director, Liniya 11, Building 18B, Vasilievsky Island, 199034 St-Petersburg, Russia C.I.S. Tel: +7 812 328 2251; Fax: +7 812 327 19 50; Mobile: +7 921 9651977; E-mail: <korsak@mcrm.ru>

**Serbia**

Prof Nebojsa Radunovic, Institute for Obstetrics and Gynecology,Visegradska 26, 11000 Belgrade, Serbia. Tel: +38 111 361 55 92; Fax: +38 111 361 56 03; Mobile: +381 63 200 204; E-mail: <radunn01@gmail.com>

Dr Sci. Nada Tabs, Klinika za ginekologiju i akuserstvo, Klinicki centar Vojvodine, Branimira Cosica 37, 21000 Novi Sad, Serbia. Mobile: +381 63 50 81 85; E-mail: <nada.tabs@yahoo.com>

**Slovenia**

Prof. Irma Virant-Klun, University Medical Centre Ljubljana, Department of Obstetrics and Gynecology, Slajmerjeva 3, 1000 Ljubljana, Slovenia. Tel: +386 1 522 60 13; Fax: +386 1 431 43 55; Mobile: +38631625774; E-mail: <irma.virant@kclj.si>

**Spain**

Mrs Irene Cuevas Saiz, Hospital General de Alicante, Infertility Dept., Av Pintor Baeza, 12, 03010 Valencia, Spain. Tel: +34 961972000; Fax: +34 91 799 4407; Mobile: +34 677245650; E-mail: <cuevas_ire@gva.es>

Dr Fernando Prados Mondéjar, Hospital de Madrid-Montepríncipe, HM Fertility Center Monteprincipe, C/Montepríncipe 25, 28660 Boadilla del Monte, Spain. Tel: +34 917 089 931; Mobile: +34 646 737 237; E-mail <fernandojprados@gmail.com>

**Sweden**

Prof. Christina Bergh, Sahlgrenska University Hospital, Department of Obstetrics and Gynaecology, Bla Straket 6, 413 45 Göteborg, Sweden. Tel: +46 31 3421000; +46 736 889325; Fax: +4631 418717; Mobile: +46 736 889325; E-mail <Christina.bergh@vgregion.se>

**Switzerland**

Ms Maya Weder, Administration FIVNAT, Postfach 754, 3076 Worb, Switzerland. Tel: +41 (0)31 819 76 02; E-mail: <fivnat@fivnat-registry.ch>

Dr med. Marco Buttarelli, Centro Cantonale di Fertilità, Ospedale Regionale di Locarno 'La Carità', Via all'Ospedale 1, 6600 Locarno, Switzerland. Tel: +41 91 811 45 38; E-mail: <fivnat@fivnat-registry.ch>

Dr Marie-Pierre Primi, Laboratoire Andrologie et Biologie de la Reproduction (LABR), Unité de Médecine de la Reproduction, Maternité 07, CHUV, 1011 Lausanne, Switzerland. Tel: +41 21 314 34 26; E-mail: <fivnat@fivnat-registry.ch>

**UK**

Mr Howard Ryan, Data Analyst H.F.E.A, 10 Spring Gardens, London SW1A 2BU, UK. Tel: +44 (0)20 7291 8203; E-mail: <howard.ryan@HFEA.GOV.UK>

Mr Richard Baranowski, Deputy Information Manager, Human Fertilization and Embryology Authority (HFEA), Finsbury Tower, 103-105 Bunhill Row, London EC1 Y 8HF, UK. Tel: +44 (0) 20 7539 3329; Fax: +44 (0) 20 7377 1871; E-mail: <richard.baranowski@hfea.gov.uk>

**Ukraine**

Professor Dr Mykola Gryshchenko, IVF Clinic Implant Ltd, Academician V.I.Gryshchenko Clinic for Reproductive Medicine, 25 Karl Marx Str., 61000 Kharkiv, Ukraine. Tel: +380 57 124522; Fax: +380 57 705070703; Mobile: +380 57 705070703; E-mail: <nggryshchenko@gmail.com>

[^1]: ESHRE Pages content is not externally peer reviewed. The manuscript has been approved by the Executive Committee of ESHRE.

[^2]: EIM Committee 2019--2021: chairman: C.W.; chairman elect: J.S.; past chairman: C.D. members: C.B., C.C.-J., M.K., T.M., A.R., A.T.-S. and S.V., V.G. is a science manager at ESHRE Central Office, Brussels. See also Appendix for contributing centres and contact persons representing the data collection programmes in the participating European countries.
